Skip to content

INOVIO PHARMACEUTICALS, INC.: 10-Q filed 2020-08-10

What INOVIO PHARMACEUTICALS, INC. reported in its quarterly report filed 2020-08-10 (fiscal Q2 2020): 45 published measures, 121 facts as tagged in accession 0001055726-20-000048.

This filing

Form
10-Q (quarterly report)
Filed
2020-08-10
Fiscal period
fiscal Q2 2020
Accession
0001055726-20-000048 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INOVIO PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-30443,185,402USD
At 2019-12-31143,951,597USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-06-30256,824,933USD
At 2019-12-31138,546,739USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-30186,264,200USD
At 2019-12-313,435,099USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-06-30215,432,713USD
At 2019-12-3122,196,097USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-128,703,059USD91
2020-01-01 to 2020-06-30-161,244,113USD182
2019-04-01 to 2019-06-30-29,387,226USD91
2019-01-01 to 2019-06-30-58,606,488USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-52,604,208USD182
2019-01-01 to 2019-06-30-56,379,331USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-01-01 to 2020-06-30176,534USD182
2019-01-01 to 2019-06-30739,808USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2020-04-01 to 2020-06-30267,187USD91
2020-01-01 to 2020-06-301,594,461USD182
2019-04-01 to 2019-06-30135,673USD91
2019-01-01 to 2019-06-302,965,579USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-06-30340,035,391USD182
2019-01-01 to 2019-06-3080,171,151USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-94,194,567USD182
2019-01-01 to 2019-06-30-27,749,510USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-901,029,768USD
At 2019-12-31-739,785,655USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2020-04-01 to 2020-06-300USD91
2020-01-01 to 2020-06-300USD182
2019-04-01 to 2019-06-30-106,771USD91
2019-01-01 to 2019-06-30-169,571USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-06-3011,323,531USD
At 2019-12-3112,773,017USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-06-307,663,988USD182
2019-01-01 to 2019-06-306,787,991USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-33,180,898USD91
2020-01-01 to 2020-06-30-58,413,166USD182
2019-04-01 to 2019-06-30-28,200,694USD91
2019-01-01 to 2019-06-30-56,735,705USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-30382,062,453USD
At 2019-12-3194,200,969USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-04-01 to 2020-06-302,846,641USD91
2020-01-01 to 2020-06-305,650,396USD182
2019-04-01 to 2019-06-302,194,783USD91
2019-01-01 to 2019-06-302,851,031USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-3037,981,975USD
At 2019-12-3131,989,321USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2020-06-3010,513,371USD
At 2019-12-3110,513,371USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2020-06-303,420,311USD
At 2019-12-313,693,851USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-06-303,513,159USD
At 2019-12-31700,073USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-3033,448,085USD91
2020-01-01 to 2020-06-3060,007,627USD182
2019-04-01 to 2019-06-3028,336,367USD91
2019-01-01 to 2019-06-3059,701,284USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-04-01 to 2020-06-3022,376,575USD91
2020-01-01 to 2020-06-3041,487,763USD182
2019-04-01 to 2019-06-3022,486,266USD91
2019-01-01 to 2019-06-3046,876,155USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-06-30158,756,411shares
At 2019-12-31101,361,034shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2020-06-30215,432,713USD
At 2019-12-3122,196,097USD
At 2019-06-3019,735,943USD
At 2018-12-3123,693,633USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-06-301,087,745,242USD
At 2019-12-31742,646,785USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2020-06-30-610,030USD
At 2019-12-31472,608USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2020-06-30186,360,469USD
At 2020-03-31187,854,103USD
At 2019-12-315,404,858USD
At 2019-06-3056,478,073USD
At 2019-03-3180,966,251USD
At 2018-12-3187,032,407USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-06-3013,265,144USD
At 2019-12-3113,783,009USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-06-3021,462,000USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2020-06-303,420,311USD
At 2019-12-313,693,851USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-06-302,555,782USD
At 2019-12-312,672,024USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-06-3066,629USD
At 2019-12-3136,943USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-06-304,591,966USD
At 2019-12-311,584,598USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2020-06-3014,853USD
At 2019-12-3192,353USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2020-06-3032,046USD
At 2019-12-3132,046USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-129,172,466USD91
2020-01-01 to 2020-06-30-162,307,870USD182
2020-01-01 to 2020-03-31-33,135,404USD91
2019-04-01 to 2019-06-30-29,579,076USD91
2019-01-01 to 2019-06-30-58,867,943USD181
2019-01-01 to 2019-03-31-29,288,867USD90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-127,856,159USD91
2020-01-01 to 2020-06-30-162,326,751USD182
2019-04-01 to 2019-06-30-28,945,681USD91
2019-01-01 to 2019-06-30-57,345,766USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-3011,071,510USD91
2020-01-01 to 2020-06-3018,519,864USD182
2019-04-01 to 2019-06-305,850,101USD91
2019-01-01 to 2019-06-3012,825,129USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-01-01 to 2020-06-301,608,060USD182
2019-01-01 to 2019-06-301,863,225USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2020-04-01 to 2020-06-30137,000USD91
2020-01-01 to 2020-06-30273,540USD182
2019-04-01 to 2019-06-30267,000USD91
2019-01-01 to 2019-06-30533,126USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-152,102USD91
2020-01-01 to 2020-06-30-577,602USD182
2019-04-01 to 2019-06-30127,512USD91
2019-01-01 to 2019-06-3091,673USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-01-01 to 2020-06-302,636,454USD182
2019-01-01 to 2019-06-300USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2020-01-01 to 2020-06-30329,960,855USD182
2019-01-01 to 2019-06-302,296,316USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-302,813,086USD182
2019-01-01 to 2019-06-30-3,186,131USD181

Inspect the source

Entity
INOVIO PHARMACEUTICALS, INC. / CIK 0001055726
Captured
2026-09-20T05:17:43.559Z
SEC response SHA-256
9bfa830827e08b2d190e6d0b4ce0274a3c0d8852b6e536b16b5cfeadcaa54cf9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001055726.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))